ANALYSIS OF THE RESULTS OF NEODJUVANT TREATMENT IN PATIENTS WITH CONSIDERATION FOR THE IMMUNOPHENOTYPICAL FEATURES OF BREAST CANCER

ANALYSIS OF THE RESULTS OF NEODJUVANT TREATMENT IN PATIENTS WITH CONSIDERATION FOR THE IMMUNOPHENOTYPICAL FEATURES OF BREAST CANCER

The efficiency of neoadjuvant chemotherapy is directly related to the expression of CD95 (FAS/APO-1) apoptosis receptor on cancer cells, which is confirmed with the pathomorphism and changes of CD95-positive cells during neoadjuvant chemotherapy (the most effective CAF regimen is cyclophosphan, doxo...

Full description

Bibliographic Details
Main Authors:	A. A. Subbotina, V. P. Letyagin, N. N. Tupitsyn, I. V. Vysotskaya, V. D. Yermilova
Format:	Article
Language:	Russian
Published:	ABV-press 2014-09-01
Series:	Опухоли женской репродуктивной системы
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/377

Similar Items

Immunophenotypic features of molecular subtypes of breast cancer
by: S.V. Chulkova, et al.
Published: (2022-10-01)

IMMUNOPHENOTYPIC CHARACTERISTICS OF INFLAMMATORY BREAST CANCER
by: A. I. Berishvili, et al.
Published: (2014-09-01)

CHARACTERISTICS OF CLINICAL PICTURE AND BIOLOGIC FEATURES OF RARE BREAST CANCER FORMS
by: G. V. Martinova, et al.
Published: (2014-09-01)

Possibilities of surgical treatment for locally recurrent and complicated breast cancer
by: V. P. Letyagin, et al.
Published: (2015-09-01)

The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study
by: Svetlana V. Chulkova, et al.
Published: (2022-11-01)

Changes in angiogenesis markers during neoadjuvant treatment for locally advanced breast cancer
by: E. A. Kim, et al.
Published: (2014-08-01)

Atypical hyperplasias of the breast
by: I. V. Vysotskaya, et al.
Published: (2015-11-01)

MEMBRANE LEc EXPRESSION IN BREAST CANCER CELLS
by: Ya. A. Udalova, et al.
Published: (2014-09-01)

Current standards for the treatment of metastatic breast cancer (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Current standards for primary breast cancer treatment (According to the proceedings of the International Conference on Breast Cancer, Moscow, January 22–24, 2014)
by: V. P. Letyagin, et al.
Published: (2014-07-01)

Cytofluorometric characteristics of molecular subtypes of breast cancer
by: L. K. Tsoi, et al.
Published: (2014-08-01)

Prognostic factors in T3–Т4N0M0 breast cancer
by: I. V. Vysotskaya, et al.
Published: (2014-08-01)

Evolution of surgical treatment for breast cancer
by: V. P. Letyagin
Published: (2014-07-01)

SURGICAL TREATMENT OF BREAST CANCER: FROM THE CONCEPT OF ERADICATION TO AESTHETIC SURGERY
by: I. K. Vorotnikov, et al.
Published: (2018-08-01)

TREATMENT OF THE T3—4N0M0 BREAST CANCER
by: K. V. Maximov, et al.
Published: (2014-09-01)

Practical guidelines for drug correction of diffuse dyshormonal dysplasia of the breast
by: I. V. Vysotskaya, et al.
Published: (2014-07-01)

The clinical and morphological features and prognosis in rare breast carcinomas
by: I. V. Vysotskaya, et al.
Published: (2014-08-01)

Reconstructive plastic operations in the treatment of patients with breast cancer
by: V. P. Letyagin, et al.
Published: (2014-07-01)

PARP inhibitors are a new area in the treatment of breast cancer
by: V. P. Letyagin
Published: (2014-08-01)

Phytotherapy in the treatment of the diffuse mastopathy
by: V. P. Letyagin, et al.
Published: (2014-09-01)

Current molecular genetic markers of breast cancer
by: N. V. Apanovich, et al.
Published: (2014-07-01)

Algorithm of the breast cancer complex treatment consider dynamics of the primary tumor immunophenotype
by: O. B. Druzhkov, et al.
Published: (2014-07-01)

MODERN CAPABILITIES OF BREAST PATHOLOGY DIAGNOSTICS
by: I. V. Vysotskaya, et al.
Published: (2015-04-01)

Immunophenotypic characteristics of brain metastases
by: G. A. Demyashkin, et al.
Published: (2018-12-01)

American Society of Clinical Oncology recommendations of Bisphosphonates administration and bone health issues in women with breast cancer. Part 1. Recommendations on Bisphosphonates use in the treatment of patients with breast cancer.
by: I. V. Vysotskaya
Published: (2014-09-01)

CONSERVATIVE SURGERY IN THE COMPLEX TREATMENT FOR EARLY BREAST CANCER
by: M. S. Pirogova, et al.
Published: (2014-09-01)

Possibilities to improve breast cancer screening
by: I. V. Vysotskaya
Published: (2014-08-01)

Adjuvant therapy for early breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

Interrelation of tumor infiltrating lymphocyte subpopulations with clinical and pathomorphological features of a breast cancer
by: O. A. Beznos, et al.
Published: (2016-09-01)

Rehabilitation of patients undergoing radical mastectomy
by: V. P. Letyagin, et al.
Published: (2014-09-01)

Pharmacological effects and molecular mechanisms of action of a herbal medicine based on Vitex agnus-castus
by: I. V. Vysotskaya, et al.
Published: (2017-05-01)

Current feasibility of endocrine therapy for breast cancer
by: I. V. Vysotskaya
Published: (2014-07-01)

Present and future of breast cancer anti-Her-2-therapy
by: V. P. Letyagin
Published: (2014-07-01)

Hormone therapy for diffuse mastopathy
by: I. V. Vysotskaya, et al.
Published: (2014-11-01)

American society of clinical oncology update on the role of bisphosphonates and bone health issues in women with breast cancer Part II. Bisphosphonates in the adjuvant therapy of breast cancer
by: I. V. Vysotskaya
Published: (2014-09-01)

CABERGOLINE IN PRACTICAL MAMMOLOGY
by: I. V. Vysotskaya, et al.
Published: (2016-12-01)

Immunophenotype and metabolism are linked in peripheral blood neutrophils from patients with kidney cancer
by: A. A. Savchenko, et al.
Published: (2020-12-01)

IMMUNOPHENOTYPIC AND CYTOGENETIC FEATURES OF ACUTE LEUKEMIA IN CHILDREN OF THE ARKHANGELSK REGION: A RETROSPECTIVE STUDYN: A RETROSPECTIVE STUDY
by: A. S. Ulanova, et al.
Published: (2021-05-01)

Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone.
by: Alberghini, M, et al.
Published: (2010)

Immunophenotype of the macrophage population in fibrous, cavernous pulmonary tuberculosis
by: E. P. Golubinskaya, et al.
Published: (2019-05-01)